| Original language | English (US) |
|---|---|
| Pages (from-to) | 1237-1240.e2 |
| Journal | Journal of Allergy and Clinical Immunology |
| Volume | 143 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 2019 |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Histologic similarities in children with eosinophilic esophagitis and proton pump inhibitor–responsive esophageal eosinophilia. / Nguyen, Nathalie; Baumgarten, Anna; Wright, Benjamin L. et al.
In: Journal of Allergy and Clinical Immunology, Vol. 143, No. 3, 03.2019, p. 1237-1240.e2.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Histologic similarities in children with eosinophilic esophagitis and proton pump inhibitor–responsive esophageal eosinophilia
AU - Nguyen, Nathalie
AU - Baumgarten, Anna
AU - Wright, Benjamin L.
AU - Capocelli, Kelley E.
AU - Pan, Zhaoxing
AU - Lee, James J.
AU - Furuta, Glenn T.
AU - Masterson, Joanne C.
N1 - Funding Information: This study was supported by grants from the Mayo Clinic, Phoenix Children's Hospital Foundation, and Don and Kathy Levin Family Foundation (to B.L.W.); United States National Institutes of Health (NIH; grant no. K01- DK106315 to J.C.M.; grant no. NIH 2T32DK067009-11 to N.N.; and grant no. 1K24DK100303 to G.T.F.) and the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) (grant no. U54AI117804). CEGIR is part of the Rare Disease Clinical Research Network, an initiative of the Office of Rare Disease Research, the National Center for Advancing Translational Sciences (NCATS), and is funded through collaboration between the National Institute of Allergy and Infectious Diseases, the National Institute of Diabetes and Digestive and Kidney Diseases, NCATS, and patient advocacy groups including APFED, CURED, and EFC. Manuscript contents are the authors' sole responsibility and do not necessarily represent official NIH views. The study sponsors played no role in the study design in the collection, analysis, and interpretation of data.Disclosure of potential conflict of interest: B. L. Wright's institution received grants from the Mayo Clinic, Phoenix Children's Hospital Foundation, and Don and Kathy Levin Family Foundation. G. T. Furuta is founder of EnteroTrack and received consultancy fees from Shire and royalties from UpToDate. The rest of the authors declare that they have no relevant conflicts of interest. Funding Information: This study was supported by grants from the Mayo Clinic , Phoenix Children's Hospital Foundation , and Don and Kathy Levin Family Foundation (to B.L.W.); United States National Institutes of Health (NIH; grant no. K01- DK106315 to J.C.M.; grant no. NIH 2T32DK067009-11 to N.N.; and grant no. 1K24DK100303 to G.T.F.) and the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) (grant no. U54AI117804 ). CEGIR is part of the Rare Disease Clinical Research Network, an initiative of the Office of Rare Disease Research, the National Center for Advancing Translational Sciences (NCATS), and is funded through collaboration between the National Institute of Allergy and Infectious Diseases , the National Institute of Diabetes and Digestive and Kidney Diseases , NCATS , and patient advocacy groups including APFED , CURED , and EFC . Manuscript contents are the authors' sole responsibility and do not necessarily represent official NIH views. The study sponsors played no role in the study design in the collection, analysis, and interpretation of data.
PY - 2019/3
Y1 - 2019/3
UR - http://www.scopus.com/inward/record.url?scp=85058371011&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85058371011&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2018.10.047
DO - 10.1016/j.jaci.2018.10.047
M3 - Article
C2 - 30445056
AN - SCOPUS:85058371011
SN - 0091-6749
VL - 143
SP - 1237-1240.e2
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 3
ER -